Research summary, original research, 2020

Neurointerventionalist and Patient Radiation Doses in Endovascular Treatment of Acute Ischemic Stroke

Klepanec A, Salat D, Harsany J, Hoferica M, Krastev G, Haring J, et al.. Cardiovascular and interventional radiology. 2020

Read the original paper

In plain language

In 179 stroke thrombectomies, the neurointerventionalist received a mean of 7.7 µSv per procedure, with higher doses linked to longer procedures, more fluoroscopy time and more passes. These are dosimeter readings, not health outcomes.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Interventional radiologists, Patients
Size
n = 179 patients
Summary based on
the abstract

What it found

  • Mean neurointerventionalist dose per thrombectomy measured by real-time dosimetry

    Key figures: 7.7 ± 7.4 µSv

  • Operator dose was associated with baseline stroke severity, puncture-to-recanalisation time, fluoroscopy time and number of passes

    Key figures: NIHSS P = 0.043; puncture to recanalisation P = 0.003; fluoroscopy time P = 0.009; passes P = 0.009

  • Local patient dose reference levels (75th percentile) for thrombectomy were defined

    Key figures: Dose-area product (DAP) 34 Gy cm2; cumulative air kerma 242 mGy; fluoroscopy time 12 min

  • Operator doses were higher than in the only prior study of operator dose in cerebral interventions, while patient reference doses were lower than previously published

  • Patient DAP was independently associated with patient body size, procedure duration, fluoroscopy time, number of passes, recanalisation success and aspiration technique

    Key figures: weight P = 0.004; fluoro time P < 0.001; passes P < 0.001; aspiration P < 0.001

Limits to keep in mind

Single-centre data from an abstract only, with no detail on dosimeter placement or shielding used; operator dose reflects one dosimeter measurement per procedure rather than organ doses or health outcomes.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.